Logo image of AED.BR

AEDIFICA (AED.BR) Stock Fundamental Analysis

EBR:AED - Euronext Brussels - BE0003851681 - REIT - Currency: EUR

61.8  +0.15 (+0.24%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to AED. AED was compared to 41 industry peers in the Diversified REITs industry. AED has a medium profitability rating, but doesn't score so well on its financial health evaluation. AED has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

AED had positive earnings in the past year.
In the past 5 years AED has always been profitable.
AED had a positive operating cash flow in 4 of the past 5 years.
AED.BR Yearly Net Income VS EBIT VS OCF VS FCFAED.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

AED's Return On Assets of 5.81% is amongst the best of the industry. AED outperforms 87.80% of its industry peers.
AED's Return On Equity of 10.32% is amongst the best of the industry. AED outperforms 85.37% of its industry peers.
AED has a Return On Invested Capital of 6.01%. This is amongst the best in the industry. AED outperforms 80.49% of its industry peers.
Industry RankSector Rank
ROA 5.81%
ROE 10.32%
ROIC 6.01%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AED.BR Yearly ROA, ROE, ROICAED.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

The Profit Margin of AED (63.80%) is better than 78.05% of its industry peers.
In the last couple of years the Profit Margin of AED has declined.
AED's Operating Margin of 80.83% is fine compared to the rest of the industry. AED outperforms 73.17% of its industry peers.
AED's Operating Margin has been stable in the last couple of years.
AED has a Gross Margin of 97.65%. This is amongst the best in the industry. AED outperforms 95.12% of its industry peers.
AED's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 80.83%
PM (TTM) 63.8%
GM 97.65%
OM growth 3Y-2.11%
OM growth 5Y-1.28%
PM growth 3Y-20.75%
PM growth 5Y-10.29%
GM growth 3Y0.24%
GM growth 5Y0.4%
AED.BR Yearly Profit, Operating, Gross MarginsAED.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80 100

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AED is destroying value.
There is no outstanding debt for AED. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
AED.BR Yearly Shares OutstandingAED.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
AED.BR Yearly Total Debt VS Total AssetsAED.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 0.95, we must say that AED is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of AED (0.95) is comparable to the rest of the industry.
AED has a Debt/Equity ratio of 0.57. This is a neutral value indicating AED is somewhat dependend on debt financing.
AED has a Debt to Equity ratio of 0.57. This is in the better half of the industry: AED outperforms 73.17% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF N/A
Altman-Z 0.95
ROIC/WACC0.98
WACC6.12%
AED.BR Yearly LT Debt VS Equity VS FCFAED.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B

2.3 Liquidity

AED has a Current Ratio of 0.32. This is a bad value and indicates that AED is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of AED (0.32) is worse than 70.73% of its industry peers.
A Quick Ratio of 0.32 indicates that AED may have some problems paying its short term obligations.
The Quick ratio of AED (0.32) is worse than 68.29% of its industry peers.
Industry RankSector Rank
Current Ratio 0.32
Quick Ratio 0.32
AED.BR Yearly Current Assets VS Current LiabilitesAED.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

6

3. Growth

3.1 Past

AED shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 937.39%, which is quite impressive.
AED shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -7.20% yearly.
The Revenue has grown by 88.17% in the past year. This is a very strong growth!
The Revenue has been growing by 23.35% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)937.39%
EPS 3Y-18.35%
EPS 5Y-7.2%
EPS Q2Q%415.37%
Revenue 1Y (TTM)88.17%
Revenue growth 3Y13.45%
Revenue growth 5Y23.35%
Sales Q2Q%319.87%

3.2 Future

The Earnings Per Share is expected to grow by 2.40% on average over the next years.
AED is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.32% yearly.
EPS Next Y1.55%
EPS Next 2Y2.29%
EPS Next 3Y2.4%
EPS Next 5YN/A
Revenue Next Year5.91%
Revenue Next 2Y5.52%
Revenue Next 3Y5.32%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AED.BR Yearly Revenue VS EstimatesAED.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
AED.BR Yearly EPS VS EstimatesAED.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 7.82, the valuation of AED can be described as very cheap.
82.93% of the companies in the same industry are more expensive than AED, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 29.07. AED is valued rather cheaply when compared to this.
AED is valuated correctly with a Price/Forward Earnings ratio of 12.36.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AED is on the same level as its industry peers.
AED is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.05, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 7.82
Fwd PE 12.36
AED.BR Price Earnings VS Forward Price EarningsAED.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AED.BR Per share dataAED.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of AED may justify a higher PE ratio.
PEG (NY)5.04
PEG (5Y)N/A
EPS Next 2Y2.29%
EPS Next 3Y2.4%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.45%, AED is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 8.11, AED is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.39, AED pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.45%

5.2 History

The dividend of AED is nicely growing with an annual growth rate of 8.22%!
Dividend Growth(5Y)8.22%
Div Incr Years2
Div Non Decr Years2
AED.BR Yearly Dividends per shareAED.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

The dividend of AED is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP0%
EPS Next 2Y2.29%
EPS Next 3Y2.4%
AED.BR Yearly Income VS Free CF VS DividendAED.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

AEDIFICA

EBR:AED (3/26/2025, 2:28:11 PM)

61.8

+0.15 (+0.24%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-19 2025-02-19/amc
Earnings (Next)04-29 2025-04-29
Inst Owners42.88%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap2.94B
Analysts79.05
Price Target71 (14.89%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.45%
Yearly Dividend2.63
Dividend Growth(5Y)8.22%
DP0%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.81%
PT rev (3m)-0.13%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0.81%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.37%
Revenue NY rev (3m)0.81%
Valuation
Industry RankSector Rank
PE 7.82
Fwd PE 12.36
P/S 4.99
P/FCF N/A
P/OCF N/A
P/B 0.81
P/tB 0.83
EV/EBITDA N/A
EPS(TTM)7.9
EY12.78%
EPS(NY)5
Fwd EY8.09%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS12.39
BVpS76.61
TBVpS74.75
PEG (NY)5.04
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.81%
ROE 10.32%
ROCE 8.01%
ROIC 6.01%
ROICexc 6.03%
ROICexgc 6.12%
OM 80.83%
PM (TTM) 63.8%
GM 97.65%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-2.11%
OM growth 5Y-1.28%
PM growth 3Y-20.75%
PM growth 5Y-10.29%
GM growth 3Y0.24%
GM growth 5Y0.4%
F-ScoreN/A
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.32
Quick Ratio 0.32
Altman-Z 0.95
F-ScoreN/A
WACC6.12%
ROIC/WACC0.98
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)937.39%
EPS 3Y-18.35%
EPS 5Y-7.2%
EPS Q2Q%415.37%
EPS Next Y1.55%
EPS Next 2Y2.29%
EPS Next 3Y2.4%
EPS Next 5YN/A
Revenue 1Y (TTM)88.17%
Revenue growth 3Y13.45%
Revenue growth 5Y23.35%
Sales Q2Q%319.87%
Revenue Next Year5.91%
Revenue Next 2Y5.52%
Revenue Next 3Y5.32%
Revenue Next 5YN/A
EBIT growth 1Y98.6%
EBIT growth 3Y11.07%
EBIT growth 5Y21.76%
EBIT Next Year10.97%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A